Janux Therapeutics (JANX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Janux Therapeutics (JANX) over the last 6 years, with Q3 2025 value amounting to -$8.1 million.
- Janux Therapeutics' Other Gross PP&E Adjustments rose 1783.18% to -$8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year increase of 1783.18%. This contributed to the annual value of -$13.2 million for FY2024, which is 1168.43% up from last year.
- According to the latest figures from Q3 2025, Janux Therapeutics' Other Gross PP&E Adjustments is -$8.1 million, which was up 1783.18% from -$7.8 million recorded in Q2 2025.
- Janux Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $2.7 million for Q1 2022, and its period low was -$18.9 million during Q2 2022.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$10.4 million (2024), whereas its average is -$9.4 million.
- As far as peak fluctuations go, Janux Therapeutics' Other Gross PP&E Adjustments plummeted by 2089294.12% in 2022, and later soared by 3494.69% in 2023.
- Quarter analysis of 5 years shows Janux Therapeutics' Other Gross PP&E Adjustments stood at $85000.0 in 2021, then crashed by 20892.94% to -$17.7 million in 2022, then increased by 15.55% to -$14.9 million in 2023, then grew by 11.68% to -$13.2 million in 2024, then soared by 38.48% to -$8.1 million in 2025.
- Its Other Gross PP&E Adjustments was -$8.1 million in Q3 2025, compared to -$7.8 million in Q2 2025 and -$8.5 million in Q1 2025.